Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Hyaluronan

    • Product Name Hyaluronan
    • Alias hyaluronic acid
    • Einecs 931-274-8
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    Specifications

    HS Code

    296501

    Chemicalname Hyaluronan
    Alternativename Hyaluronic Acid
    Molecularformula C14H21NO11n
    Molecularweight Variable (depending on polymer length)
    Casnumber 9004-61-9
    Physicalappearance White to off-white powder or fibrous material
    Solubility Highly soluble in water
    Phrange 5.0 - 8.0 (in solution)
    Biologicalsource Produced naturally in connective, epithelial, and neural tissues
    Mainuses Cosmetics, pharmaceuticals, wound healing, ophthalmology
    Stability Stable under normal conditions, but susceptible to enzymatic degradation
    Viscosity Forms highly viscous solutions
    Charge Anionic (negatively charged)
    Odor Odorless
    Origin Biosynthesized or extracted from animal and microbial sources

    As an accredited Hyaluronan factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing A 10g white HDPE screw-cap bottle labeled "Hyaluronan, 10g, USP grade, store at 2-8°C, for laboratory use only."
    Shipping Hyaluronan is shipped in sealed, airtight containers to protect it from moisture and contamination. It is typically transported at room temperature unless otherwise specified, and labeled according to regulatory requirements. Care is taken to avoid exposure to extreme temperatures or direct sunlight during transit to maintain product integrity.
    Storage Hyaluronan should be stored in a tightly sealed container, protected from light and moisture. It is best kept at 2–8°C (refrigerated) to maintain stability and prevent degradation. Avoid repeated freeze-thaw cycles if stored as a solution. For long-term storage, keep hyaluronan as a dry powder at -20°C. Always follow the manufacturer's recommendations for optimal storage conditions.
    Application of Hyaluronan

    Applications of Hyaluronan in Industrial Manufacturing

    As a chemical raw material manufacturer with established expertise in hyaluronan production, we supply high-purity grades adapted for a range of precisely regulated industrial sectors. Each application below reflects direct, large-scale manufacturing uses adopted by commercial producers across targeted downstream fields.

    1. Injectable Medical Devices for Osteoarthritis and Ophthalmic Surgery

    Medical device manufacturers rely on our hyaluronan for formulating intra-articular joint injections and ophthalmic viscoelastic devices. The stringent purity and biocompatibility profile enables direct integration into device filling under aseptic conditions. Hyaluronan is hydrated and filtered, then compounded into finished solutions in ISO 5 cleanrooms. Our teams directly support OEM production with documentation and validated COAs for batch release, conforming to global device quality regimes.

    Industry compliance standards

    • USP, EP, JP monographs for sodium hyaluronate (for injection)
    • ISO 13485: Medical Device Quality Management System (QMS)
    • 21 CFR 820 (FDA Quality System Regulation for devices, US)
    • Ph. Eur. and Chinese Pharmacopoeia (ChP) injection requirements

    Typical usage ratio

    • 10–20 mg/mL, customized to injection viscosity and osmolality. Dosing adjusted based on device format, target anatomical site, and desired rheology characteristics.

    Downstream process integration

    • Hydration and sterilization under nitrogen atmosphere
    • Final blending with buffer solution and excipients in aseptic tanks
    • Sterile filtration (0.22 μm), then filling into pre-sterilized syringes or vials
    • Endotoxin testing and QC before terminal sterilization or final packing

    Final product types

    • Sterile pre-filled syringes for intra-articular (knee/hip/shoulder) injections
    • Viscoelastic agents for cataract and retinal surgery
    • Ophthalmic lubricating gel or solution for dry eye management

    2. Topical Dermal and Cosmetic Formulations

    Major skincare and beauty manufacturers incorporate our hyaluronan as a moisture-binding agent for premium creams, serums, and masks. Its high molecular weight enhances long-lasting surface hydration, while low molecular weight grades penetrate deeper skin layers. Our production batches meet cosmetic GMP, with precise molecular weight profiles to support desired product characteristics and stability through heated emulsification, homogenization, and cold compounding.

    Industry compliance standards

    • ISO 22716: Cosmetic Good Manufacturing Practices (GMP)
    • China GB 7916 Hygiene Standards for Cosmetic Ingredients
    • EU Cosmetic Regulation (EC) No 1223/2009 – Annexes III & IV
    • IFRA guidelines for skin compatibility

    Typical usage ratio

    • 0.1–2% w/w (by total formulation mass); typical serums use 0.5–1%, lotions 0.2–0.5%, and sheet masks up to 2% for intensive hydration. Technologists select grade and dosage depending on desired tactile feel and molecular penetration depth.

    Downstream process integration

    • Dissolving in deionized water during cold or hot mixing stage
    • Pre-hydration with other actives before emulsification for oil-in-water crèmes
    • Final blending followed by vacuum homogenization or microfluidization
    • Bulk filling into sterile cosmetic jars, tubes, or single-dose ampoules

    Final product types

    • Anti-aging facial serums
    • Moisturizing face and body creams/lotions
    • Hydrogel face masks
    • Under-eye patches and plumping lip balms

    3. Oral Dietary Supplements and Functional Foods

    Hyaluronan features in chewable tablets, capsules, and liquid drinks developed by nutraceutical and functional food processors. Bioavailability and purity are critical: our food-grade material passes exhaustive testing for heavy metals, endotoxins, and residual solvents. Downstream recipes often specify particular oligomer size distributions to enhance gastrointestinal absorption, with addition managed during blending or tableting under HACCP and FSSC 22000 controls.

    Industry compliance standards

    • FDA 21 CFR 172.872 (GRAS affirmation for hyaluronic acid as a food ingredient)
    • EU Novel Food Regulation (EU) 2015/2283 approval
    • GB 29924-2013 (China Food Safety National Standard for food additives)
    • FSSC 22000 and HACCP dietary supplement protocols

    Typical usage ratio

    • 20–200 mg per daily dose depending on formulation (ranges: 0.01–0.1% weight for beverages, 30–120 mg/unit for tablets/capsules). Nutritionists and process engineers select loading according to regional recommended intake and delivery format.

    Downstream process integration

    • Dry blending with excipients and actives before direct compression or granulation (tablets)
    • Premarketing solubility trials for inclusion in ready-to-drink (RTD) liquid shots
    • Encapsulation or agglomeration for powdered mixes
    • Batch-specific QC: moisture, microbial load, and bulk density validation

    Final product types

    • Joint-health and skin-support chewable tablets/capsules
    • Functional beverages and liquid ampoules
    • Stick packs for direct oral consumption
    • Meal replacement formulations with bioactive enhancement

    4. Veterinary Pharmaceuticals and Animal Health Products

    Veterinary product manufacturers integrate our hyaluronan in injectable and oral preparations for companion and livestock animals. The primary application involves intra-articular injections for equine and canine osteoarthritis, and oral solutions for joint and skin health in cats, dogs, and horses. Regulatory documentation, veterinary GMP batch histories, and endotoxin validation accompany all animal-grade shipments for straightforward QP release and downstream compounding.

    Industry compliance standards

    • Pharmacopeia monographs (EP, USP Vet Compendium)
    • EU EudraLex Volume 4: GMP for Veterinary Medicinal Products
    • FDA Animal Drug Regulations (21 CFR 500–589)
    • APVMA (Australia) and PMRA (Canada) veterinary additive requirements

    Typical usage ratio

    • 5–20 mg/mL for injectable solutions, adjusted based on animal species and joint size; 1–10 mg/tablet or 2–50 mg/day for oral supplements, tailored during formulation based on animal body weight and type of dosing (chronic maintenance or acute care).

    Downstream process integration

    • Solution hydration, clarification, and sterile filtration for injectables
    • Dry blending for tablet or powder dosing forms
    • Pre-filling and sealed dosing into species-specific packaging (oral syringes, boluses, sachets)
    • Production monitored under dedicated veterinary cleanrooms and cross-contamination prevention SOPs

    Final product types

    • Equine/canine/feline joint injection solutions
    • Oral veterinary supplements (powders, tablets, pastes)
    • Compounded in-clinic animal health mixtures
    • Companion pet functional treats with joint-health claims

    5. Advanced Wound Care and Hydrogel Dressings

    Specialty medical dressing manufacturers utilize our medical-grade hyaluronan to construct hydrogel matrices for moist wound therapies. Its biocompatibility and hydration capacity support chronic and acute wound recovery in diabetic foot ulcers, burns, and trauma cases. The raw material enters at various points, such as hydrogel solution formation, film casting, or during freeze-drying protocols, and must demonstrate trace endotoxin, consistent viscosity, and proven sterility.

    Industry compliance standards

    • ISO 10993 Biocompatibility Testing
    • FDA 510(k) Medical Device Premarket Submission (for wound dressings)
    • EN 13726 requirements for primary wound dressings
    • USP/NF monograph for sodium hyaluronate (device excipient)

    Typical usage ratio

    • 1–5% w/w in hydrogel matrix depending on desired water absorption, viscosity, and dressings’ application (sheet, gel, or adhesive film). Product engineers adjust based on wound exudate levels and intended wear time.

    Downstream process integration

    • Dissolution in water or saline during hydrogel formulation
    • Casting or extrusion into film/foam layers for adhesive or layered dressings
    • Cross-linking with other biopolymers or addition to lyophilization lines for sponge forms
    • Terminal sterilization (gamma irradiation or ETO) before final sterile packaging

    Final product types

    • Non-adherent hydrogel wound dressings
    • Bioactive burn patches
    • Sheet or film dressings for chronic ulcers
    • Sterile hydrogel fillers for surgical and dental use

    Free Quote

    Competitive Hyaluronan prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Hyaluronan: Innovation and Expertise from Direct Manufacturing

    Real-World Use Shapes Our Hyaluronan

    Hyaluronan, more widely known as hyaluronic acid, has come a long way since early days of extraction from animal sources. Our manufacturing team knows what it takes to raise quality and purity beyond the bulk supplies found in most markets. Each batch starts with pharmaceutical-grade fermentation processes, not leftovers from animal by-products. Our team manages every step, choosing only the cleanest, traceable raw materials. This approach doesn’t just cut down on the risk of allergies and contamination—it also means the hyaluronan we ship comes certified for the strictest cosmetic and medical standards.

    Over the last decade, customers have come to expect consistent, reliable viscosity and molecular weights. Our SERIXA™ HA-10 (molecular weight 1.0–1.5 MDa), SERIXA™ HA-300 (300 kDa), and SERIXA™ HA-2000 (2.0–2.5 MDa) models were developed in partnership with research groups testing stability, solubility, and performance in demanding applications. Higher molecular weight versions like HA-2000 create longer-lasting, more elastic hydration films for premium skincare and injectable formulations. The mid-weight (HA-10 and HA-300) provides better absorption for serums and eye drops. We focus on this range for a reason: customers in medical, cosmetic, and veterinary fields want proven options—not just fancy branding.

    Not All Hyaluronan Works the Same

    Seeing everything from poor solubility to trace proteins slip through in cheaper brands, we set up routine third-party mass spectrometry checks and our own internal HPLC tests. Pharmaceutical and injectable customers insist on precise, ultra-low endotoxin levels. Our purification eliminates pyrogens and residual proteins with high-pressure membrane filtration. This not only keeps the product safe, but it delivers a neutral odor and clarity in solution that pleases even the strictest quality heads in multinational pharma labs.

    On top of ultra-pure powder, we also offer sodium hyaluronate in solution, designed to dissolve immediately with minimal shearing—even in challenging cold-mix or low-salt conditions. Many of our clients switched to our hyaluronan after struggling to get their finished product viscosity within spec using generic supplies. The difference shows up in every real-world test: less clumping, less loss during transfer, more predictable shelf life. We have direct data from pilot-scale skin patch and ophthalmic production lines that show lower batch-to-batch variation than EU pharmacopoeia minimums.

    Meeting Tight Regulatory Demands

    From the start, our plant built out its cleanroom manufacturing and sterile packaging lines to reach the standards needed for regulated export. Our hyaluronan powders and solutions carry documentation for European and Japanese pharmacopoeia, and both USP and EP monographs. Clean fill-finish work, redundant filtration, and tamper-resistant packaging come from high-stakes experience—our management team started in the injectable antibiotics sector, where contamination and recalls can destroy a business overnight.

    Real GMP experience teaches what’s critical for global customers. For instance, every shipment destined for intra-articular injection or eye surgery goes through lot-specific endotoxin and protein content validation. Production files also archive full traceability back to premix fermentation tanks—a deep dive lets us spot any deviation fast and recall if something ever slips, a safeguard most brokers or relabelers simply cannot offer.

    Supporting Customer Research and Product Development

    A huge part of our production volume now goes to R&D labs and high-value consumer products. Thanks to our engineering group’s close ties with academic researchers, we’ve adapted our processes for both classic and custom-modified hyaluronan. Cross-linkable grades, thiolated and methacrylated variants, as well as pharmaceutical sodium hyaluronate for ophthalmic and orthopedic applications, can all be shipped from the same plant where basic food or cosmetic grade starts. Technical staff from our plant often work with customers to adjust molecular weight or optimize for special cross-linking chemistries. One recent project involved reformulating a medical wound dressing to keep viscosity stable despite extreme pH swings. In these cases, it’s more than just shipping powder; it’s troubleshooting, sampling, and documentation at every step.

    Every member of our support team has worked hands-on with actual production lines. Advice isn’t pulled from a marketing script—it comes from real-world troubleshooting, batch failures, and hundreds of small improvements over years of process optimization. When a skin care startup could not compound a stable serum, we visited, diagnosed the filtration setup, and suggested a blending schedule to prevent localized clumping. Their product line launched on time. This hands-on approach gives us repeat business and trustworthy relationships.

    Differences from Common Hyaluronan Products

    Supply chains for ingredients like hyaluronan can look similar on paper, but the differences start at fermentation. Many commercial hyaluronic acids come from animal tissues, then refined using basic alcohol precipitation and single pass filtration. Protein, nucleic acid, or impurity content often runs higher than what regulated applications allow. Those cuts end up in cheaper skin creams or pet gels. Once we invested in plant-based fermentation, our input costs increased, but the trade-off for purity and bio-safety pays off when customers rely on ingredients to meet strict standards.

    Hyaluronan’s science has exploded in the last few years, especially as injectable and nano-formulated products reach the market. Demand for precise molecular weights, tight size distributions, and impurity controls has outstripped legacy supplier capabilities. Unlike companies relying on old animal-based extraction lines, we invested early in high-throughput chromatography and multi-stage membrane purification. Our main reactor trains feature dynamic, real-time process feedback, which means we adjust pH, feed rates, and agitation based directly on in-process analytics. Downstream, our integrated purification skips the older, more wasteful chemical precipitation that tends to strip away high-molecular-weight fractions.

    In the finished product, the difference shows up quickly. One international pharmaceutical client tested solution clarity and found our lots scored 20% lower in absorbance than competitors, a strong sign of lower residual peptide and nucleic acid content. Consistency in molecular weight distribution delivers predictable thickening for medical gels and zero irritation for sensitive personal care lines. Every major step in our plant—from raw material intake to final fill—follows protocols more stringent than basic food-grade systems. These upgrades translated into fewer customer complaints and near-zero regulatory warnings.

    Responding to Cutting-Edge Applications

    The journey from animal-based hyaluronan to precision-fermented, pharmaceutical-grade material has become a necessity, not a luxury. Our customers continue to push into newer fields: subcutaneous fillers, tissue engineering, sustained-release implants, and advanced wound healing dressings. Their work requires predictable rheological behavior and purity at the parts-per-million level. We’ve adapted by introducing onsite molecular weight fractionation and deep purification with virus-removal capability.

    Our role doesn’t stop at the production gates. We gather field feedback from researchers and manufacturers who use the product on real assembly lines and in clinical trials. This feedback loop feeds directly back into continuous process improvements. In one case, clients from a European biotech firm struggled with unexplained gelation during the formulation of a drug-eluting stent. Our process engineers reviewed their formulation steps, supplied a custom molecular weight cut, and helped adapt their blending order. The stents cleared clinical hurdles thanks in part to this collaboration.

    Medical device makers have adopted our pre-sterilized, injectable syringes filled with hyaluronan solutions for viscoelastic eye surgery and arthritis injections. Each lot comes with depth-tested certificates covering all relevant pharmacopeia standards. A dedicated cleanroom line handles only injectable grades to eliminate cross-contamination risks with lower-purity runs.

    How Our Manufacturing Approach Matters

    Many in the industry treat hyaluronan as a simple commodity, focusing purely on price. Our experience says otherwise. Time and again, new clients send us competitor samples that fail to dissolve or smell “off.” Each failed batch tells a story. Bad batches aren’t just a supplier headache—they cost real dollars for companies that lose production time and must discard valuable ingredients. We use in-process quality checks rather than end-stage testing alone. Our team prefers to solve problems at the source, not when products are already loaded onto a truck.

    The industry’s best practices develop from both failure and success. Our facility has dealt with microbial contamination events in years past, leading us to overhaul air filtration and raw material quarantine procedures. We upgraded fermentation tanks to self-cleaning, fully enclosed vessels and added UV sterilization to water feeds, steps that paid dividends during later surges in demand. This level of vigilance results in a safer end product but also in firm schedules that our customers can depend on.

    Building Trust Through Experience and Results

    A core part of our reputation comes from willingness to share technical data and address tough questions from customers and regulators. Over dozens of audits from industry partners and health authorities, we demonstrate our process openness. Visitors see real-time production logs, validated cleanroom procedures, and documentation mapping every ingredient lot to its finished batch. This transparency sets expectations and reassures clients—from major pharmaceutical companies to boutique skincare labs—that the material they receive has been made with safety top of mind.

    Problems can and do arise in the world of manufacturing. Raw material shortages, unforeseen equipment downtime, or staff turnover all impact output. Our plant keeps safety stock and maintains cross-trained staff to limit disruption, and we keep an open feedback channel to inform customers about shipping timelines or production updates. Suppliers who dance around delays or quality issues rarely keep repeat business for long.

    Every hyaluronan model we ship carries a story—a set of process milestones, audits, and real-world applications. We use each setback as an improvement opportunity. One key change last year: dialing in more sensitive in-line molecular weight sensors to detect process shifts even earlier. These improvements may not show up on data sheets, but they drive fewer customer headaches and greater long-term loyalty.

    Looking Ahead: Continuous Improvement

    As customer needs shift, our manufacturing evolves with them. The growing interplay between hyaluronan and emerging technologies such as 3D-printed scaffolds, nano-formulated carriers, and even targeted drug-delivery platforms brings higher expectations. The challenge is not just to keep up, but to lead in technical development and reliability. Our close relationships with customer R&D teams position us to respond quickly to experimental requests, offer honest technical advice, and share application notes gleaned from multiple markets.

    Long partnerships come from shared problem-solving. That means providing not only consistent hyaluronan but also process recommendations, data transparency, and responsive logistics. It’s this face-to-face, hands-on approach that turns a base material into a critical enabler of medical progress and consumer safety. Hyaluronan is more than a trend—it’s a platform for innovation and trust, built by people who know manufacturing from the ground up.